FDA approves alirocumab, first injectable lipid-lowering biologic therapyJuly 24, 2015CAD & AtherosclerosisAcute Coronary SyndromesLipid Disorders
ACC/AHA cholesterol guideline found efficient, cost effectiveJuly 14, 2015CAD & AtherosclerosisLipid Disorders
VA/DOD guideline on dyslipidemia recommends changeJune 22, 2015Lipid DisordersAcute Coronary Syndromes
ADA: Thiazolidinediones, sulfonylureas best DPP-4s for metformin-based dual GLTJune 15, 2015DiabetesLipid Disorders
FDA panel backs evolocumab for lowering LDL in high-risk patientsJune 11, 2015Lipid DisordersCAD & AtherosclerosisBusiness of Medicine
AACE: Saroglitazar found safe, effective for management of diabetic dyslipidemiaJune 10, 2015Lipid DisordersDiabetes
ELIXA trial: No cardiovascular risk with GLP-1 receptor agonist lixisenatideJune 9, 2015DiabetesAcute Coronary SyndromesLipid DisordersHeart Failure
FDA panel set to review two biologic lipid-lowering drugs for approvalJune 8, 2015Lipid DisordersCAD & Atherosclerosis
Tight glycemic control: Somewhat fewer CV events, same mortalityJune 3, 2015Lipid DisordersDiabetesHeart Failure
OARSI: Chronic conditions complicate osteoarthritis treatment, complianceMay 29, 2015DiabetesLipid DisordersHypertension
